Houston Airport Systems launches app to improve accessibility

flight plan

The Access Houston Airports is optimized with tools for children with developmental disabilities to use during their travels in and out of Houston. Photo courtesy of the Houston Airport System

Houston's two airports have a new digital tool to help its passengers with developmental disabilities better navigate their journey in and out of town.

George Bush Intercontinental Airport and William P. Hobby Airport have partnered with Chicago-based Autism innovation company, Infiniteach, to launch the Access Houston Airports mobile app. The free technology provides tools to children with autism or other conditions — as well as their caregivers — throughout their Houston Airport System experience.

"Houston Airports continues to embrace technology to go the extra mile to assist passengers of all abilities on their journey through our airports," says Jesus Saenz, Houston Airports' COO, in a news release.

The Centers for Disease Control and Prevention estimates that 13 percent of the United states have an "invisible" developmental disability like autism. Tim Joniec, the director of government relations and Americans with Disability Act coordination at HAS, says in the release that this translates to 20,000 daily Houston travelers.

"Houston Airports is introducing this app to ease anxiety for these families and provide information and resources that will make their visit to the airport an engaging and meaningful experience," Joniec says in the release.

The app uses researched-based strategies and features, including guides, short picture stories, scheduling tool, checklist feature, as well as caregiver information like terminal maps and support.

The app launch is just one improvement HAS has made. The organization has also conducted employee disability awareness training, Aira technology for the blind or low vision, service dog familiarization training, and nonprofit involvement through Southwest Airlines and United Airlines' annual Wings for all event.

Users can set a schedule for themselves, which can give them some comfort as they travel and accomplish tasks. Courtesy of HAS

Houston First Corp. will sponsor the Aira technology at several venues across the city so that the blind and vision impaired can enjoy each area. Photo by Micahl Wycoff

Low-vision technology allow for the seeing impaired to have access to Houston venues

Eyes to see

A partnership between the Houston First Corporation and Aira, an app that helps blind and low-vision people gain independence by navigating tasks and public spaces, is now live at venues around the city.

Houston First will cover the costs of use for the app in its venues, including the George R. Brown Convention Center, Avenida Houston, Wortham Theater Center, and Jesse H. Jones Hall for the Performing Arts. The organization has plans to expand to the Miller Outdoor Theatre, said John Gonzalez, senior vice president of operations and general manager for Houston First.

"Technology is changing the experiences users have at our events," Gonzalez said. "We want to make our venues as accessible as possible."

California-based Aira's role in offering a vessel for facilities to be more accessible to low-vision and blind Houstonians is groundbreaking, said Vince Morvillo, an account executive with Aira who is blind.

"This technology is as important to a blind person as it is to a sighted person," Morvillo said. "You, as a person with sight, have the opportunity to look, to see things, to interact with people. When you're blind, you're not out and about; you don't have too many people to interact with. The ability to be able to go and do something when you choose to do so is really important."

The app essentially creates sight on demand. Users can use the Aira app on their smartphones and be connected to a trained operator, who will help them navigate the scene around them using video being fed to the app through their phone. The operators will then guide the user to their destination or even help them with everyday necessities like grocery shopping.

"The blind world needs this," Morvillo said. "This technology gets blind people out in the world. Businesses know how successful they are by how many people support them. I just don't understand why blind people are an untapped resource. Nobody's out there trying to get the blind shopper."

In addition to the blind population, Morvillo says that this will also help the aging population, who may often struggle with their vision later in life, and will increase accessibility options around the city.

Aira and Houston First's efforts to increase accessibility for patrons are now being recognized nationally. The National Federation of the Blind recently announced it would be bringing its annual convention to Houston in 2020.

"We are thrilled to host the group and are committed to providing a safe and enjoyable experience for all visitors," Houston First said in an email to InnovationMap. "It is our goal that Houston First venues provide an entertaining and immersive experience for all guests, and our partnership with Aira puts us one step closer to achieving that goal."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings